Q32 Bio Inc. Debt Securities, Available-for-sale, Amortized Cost
Q32 Bio Inc. (FIXX) had Debt Securities, Available-for-sale, Amortized Cost of $9.99 million as of 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2024-08-08
- 2024-06-30: Debt Securities, Available-for-sale, Amortized Cost $9.99M.
- 2024-03-31: Debt Securities, Available-for-sale, Amortized Cost $19.81M.
- 2023-12-31: Debt Securities, Available-for-sale, Amortized Cost $43.39M.
- 2023-09-30: Debt Securities, Available-for-sale, Amortized Cost $74.22M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost | Debt Securities, Available-for-sale, Amortized Cost as first filed |
|---|---|---|
| 2024-06-30 | $9.99M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $19.81M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $43.39M 10-K · filed 2024-03-13 | |
| 2023-09-30 | $74.22M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $50.36M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $110.75M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $141.44M 10-K · filed 2024-03-13 | |
| 2022-09-30 | $158.37M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | $49.38M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $8.00M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $47.50M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $91.73M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $96.98M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $84.26M 10-Q · filed 2021-05-06 | |
| 2020-06-30 | $206.38M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $234.70M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $208.43M 10-K · filed 2021-03-11 | $261.95M 10-K · filed 2020-03-12 |
| 2019-09-30 | $177.75M 10-Q · filed 2020-11-09 | $269.95M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $295.13M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $187.48M 10-Q · filed 2019-05-13 | |
| 2018-12-31 | $214.34M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $237.98M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $254.99M 10-Q · filed 2018-08-13 | |
| 2017-12-31 | $122.34M 10-K · filed 2019-03-12 | $122.34M 10-Q · filed 2018-08-13 |